Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)

“…<p>Genes whose expression was decreased by 1 mM ouabain by more than 2-fold.</p>…”

Long COVID prevalence decreases with vaccine uptake in the U.S. by Manlio De Domenico (626037)

Subjects:

AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased. by Margaret Coates (6058580)

“…Genes represented in red are upregulated by >2-fold in HS lesional skin (p-adj < 0.05). Genes represented in blue are downregulated by >2-fold in HS lesional skin (p-adj < 0.05). …”

Fig 2 - by Lingru Ruan (18995544)

Heat map showing time dependent changes for all genes with a ≥ 2-fold maximal increase or decrease in gene expression (mRNA) in response to single doses of IFN-γ. by Daniel R. Ambruso (12042605)

Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

“…<i>parva</i> cells treated with different concentrations of MeJA (10, 20, 50, 100 μM) and GA3 (10, 20, 50, 100 μM). The high concentrations of MeJA (10–100 μM) inhibited the accumulation of carotenoid, and the relative expression of <i>DpAP2</i>, <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> decreased significantly. …”

Decreased biofilm formation in the Δ<i>tad123</i> mutant cells. by Tra-My Duong-Nu (7300970)

GSK343 treatment decreased <i>in vivo</i> tumor volume and growth. by Laura V. Bownes (10276762)

“…Tumor volumes were monitored three times per week. (A) Animals treated with GSK343 had significantly decreased fold change in tumor volumes compared to mice treated with vehicle. …”

TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…<p>(<b>A</b>) The expression levels of ER stress markers (P-PERK 0.6±0.1-fold, p<0.001, n = 5; PERK 0.7±0.1-fold, p = 0.00364, n = 5; P-IRE1α 0.6±0.0-fold, p<0.001, n = 5; IRE1α 0.6±0.1-fold, p<0.001, n = 5; GRP78 0.8±0.1-fold, p<0.001, n = 5; cleaved ATF6 0.1±0.0-fold, p<0.001, n = 5; spliced XBP1 0.3±0.0-fold, p<0.001, n = 5; 2 males and 3 females) are all decreased while the N-glycosylated VEGFR2 is increased (3.5±0.2-fold, p<0.001, n = 5) in HOX neonatal lungs at P10 indicating TUDCA can attenuate hyperoxia-induced ER stress. …”

Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

“…<i>parva</i> cells treated with different concentrations of MeJA (10, 20, 50, 100 μM) and GA3 (10, 20, 50, 100 μM). The high concentrations of MeJA (10–100 μM) inhibited the accumulation of carotenoid, and the relative expression of <i>DpAP2</i>, <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> decreased significantly. …”

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

Observational study on Swedish plaque psoriasis patients receiving narrowband-UVB treatment show decreased S100A8/A9 protein and gene expression levels in lesional psoriasis skin but no effect on S100A8/A9 protein levels in serum by Albert Duvetorp (6454001)

Analysis of WST-1 assay. by Deepu Dowarha (5673440)

Subjects:

List of 186 genes that were increased more than 2-fold from control to galactose and decreased more than 1.5-fold from galactose to 2ME2. by Masaru Takashima (13851129)

“…The column of Galactose vs. 2ME2 shows the number of fold decrease in expression from Galactose to 2ME2.…”

Illustrations of the SeqFold2D network and the Stralign dataset. by Xiangyun Qiu (316117)

Exploration of the connected interface (S100A1/MDM2) section in S100A1. by Deepu Dowarha (5673440)

Subjects:

Exposure profiles for 100 agents are arranged in decreasing order then averaged. by Riti Bahl (11292441)

Log2 fold changes in control and ATRX knockdown HFFs upon IFN-β stimulation. by Anne-Charlotte Stilp (3520415)

Fold change of embryo viability. by Isaac Adatto (348962)

Cross sectional muscle area of cervical skeletal muscles in a patient with low skeletal muscle mass. by Anouk W. M. A. Schaeffers (17458016)

Subjects: